T1	Participants 77 135	intracavitary therapy for carcinoma of the uterine cervix.
T2	Participants 295 326	carcinoma of the uterine cervix
T3	Participants 598 925	Between January 1983 and February 1989, a total of 165 patients with carcinoma of the uterine cervix was entered in a prospective randomized study concerning the point A dose of HDR therapy (6 Gy/fraction vs 7.5 Gy/fraction) and external irradiation dose at Department of Radiation Therapy, The Center for Adult Diseases, Osaka
